Developer docs
API playgroundTry for free, no card

Search company profiles

Exactis Innovation

Full company profile

uuid002qffw

Namestring
Exactis Innovation
Websiteurl
exactis.ca
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Exactis Innovation is a Montreal-based, Canadian non-profit organization operating in the clinical trials sector. Founded in 2014, the company is privately held and structured as a non-profit, consistent with organizations that coordinate, support, or run clinical research programs on behalf of academic investigators, patient cohorts, or research consortia in Canada. Its headcount of 11 to 50 employees places it in the small-organization bracket typical of niche clinical trial non-profits that combine operational study coordination with research-support functions.

The firm's intended functional role, based on its self-description as a clinical trials company, is to serve one or more of the standard stakeholder groups in the clinical research value chain — sponsors, investigators, sites, or patient participants — but specific programs, therapeutic focus areas, study pipelines, partnerships, or service offerings could not be verified from the source material. All product-and-services, pricing, partnership, customer, technology, and management-team fields in the input are empty; the firm's primary web property (exactis.ca) is currently returning a cPanel hosting error page rather than operational content. This means the recorded firmographic identity (non-profit, Montreal, 2014, 11-50 staff) is the only externally verifiable footprint, and operational status, active programs, and current scale cannot be confirmed from the available data.

Revenue model details, funding sources, and go-to-motion are not disclosed in the input. As a non-profit, the organization would conventionally be funded through a mix of grants, institutional contributions, study contracts, and/or government program funding rather than commercial product pricing, but no specific revenue mechanics, donor base, or grant history are available to substantiate that inference. Investors and acquirers evaluating this entity should treat the public record as a thin firmographic shell pending direct primary-source verification of current operating status.

Short descriptiontext

Exactis Innovation is a Montreal-based Canadian non-profit clinical trials organization founded in 2014, employing 11–50 staff to support clinical research programs, though its current operating status and specific service scope could not be verified from available sources.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMontreal, Canada
HQ citystring
Montreal
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
clinical trials, cancer research, patient recruitment, biomedical research, clinical research services
Industry1 code
PRIMARYHLAAANAI
Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Trials Services
Social media profiles1 record
Cost components4 values
Personnel, Operations, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Exactis Innovation is a non-profit clinical trials organization that designs, coordinates, and conducts clinical studies. It operates as a research entity based in Montreal, supporting the development and evaluation of medical therapies through structured trial programs.

Differentiator
Functional benefit
Problem solved
No data
Peers10 records
TypeOthers
Description

Canadian non-profit funder of genomics and precision-health research; comparable ecosystem participant whose grants and cohorts can enable precision-trial work similar to what Exactis supports.

TypeBroad incumbent
Description

Major life-sciences cloud platform (Vault CDB, Vault CTMS, Vault eTMF); comparable as the dominant commercial infrastructure provider for clinical trials enablement globally.

TypeDirect peer
Description

Mid-sized clinical data services and biometrics CRO with strong precision-medicine and patient-reported outcomes capabilities; comparable in scale and clinical-trial enablement focus.

TypeBroad incumbent
Description

Global clinical trial endpoint technology and eCOA/ePRO provider; comparable as an enablement partner for decentralized and precision trial designs, though much larger and commercial.

5Deep 6 AI
TypeEmerging player
Description

AI-driven patient matching and clinical trial recruitment platform; comparable as a precision-trial enablement player with overlapping patient-matching value proposition.

TypeBroad incumbent
Description

Industry-leading clinical trial technology platform (Rave EDC, Rave RTSM, Medidata AI); the broad incumbent whose software stack is used by most sponsor-led precision trials and which Exactis would partner with or work alongside.

TypeDirect peer
Description

Non-profit translational cancer research institute that enables precision-medicine clinical trials in Ontario; directly comparable as a Canadian non-profit in clinical trial enablement for precision oncology.

8Canadian Cancer Trials Group
TypeDirect peer
Description

Canadian non-profit cooperative oncology trials group based at Queen's University; comparable as a non-profit clinical trials enablement organization operating in Canada with academic and sponsor partnerships.

TypeOthers
Description

Federal funding agency that supports Canadian clinical trial networks; relevant as a comparable non-profit operating environment and likely funder/partner ecosystem for Exactis.

10C3 Research Associates
TypeEmerging player
Description

Niche clinical research site network focused on community-based precision trials; comparable as a smaller specialist in trial enablement and site management.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Exactis Innovation

Clinical Trials Servicesexactis.ca

Exactis Innovation is a Montreal-based Canadian non-profit clinical trials organization founded in 2014, employing 11–50 staff to support clinical research programs, though its current operating status and specific service scope could not be verified from available sources.

What Exactis Innovation does

Exactis Innovation is a Montreal-based, Canadian non-profit organization operating in the clinical trials sector. Founded in 2014, the company is privately held and structured as a non-profit, consistent with organizations that coordinate, support, or run clinical research programs on behalf of academic investigators, patient cohorts, or research consortia in Canada. Its headcount of 11 to 50 employees places it in the small-organization bracket typical of niche clinical trial non-profits that combine operational study coordination with research-support functions.

The firm's intended functional role, based on its self-description as a clinical trials company, is to serve one or more of the standard stakeholder groups in the clinical research value chain — sponsors, investigators, sites, or patient participants — but specific programs, therapeutic focus areas, study pipelines, partnerships, or service offerings could not be verified from the source material. All product-and-services, pricing, partnership, customer, technology, and management-team fields in the input are empty; the firm's primary web property (exactis.ca) is currently returning a cPanel hosting error page rather than operational content. This means the recorded firmographic identity (non-profit, Montreal, 2014, 11-50 staff) is the only externally verifiable footprint, and operational status, active programs, and current scale cannot be confirmed from the available data.

Revenue model details, funding sources, and go-to-motion are not disclosed in the input. As a non-profit, the organization would conventionally be funded through a mix of grants, institutional contributions, study contracts, and/or government program funding rather than commercial product pricing, but no specific revenue mechanics, donor base, or grant history are available to substantiate that inference. Investors and acquirers evaluating this entity should treat the public record as a thin firmographic shell pending direct primary-source verification of current operating status.

Exactis Innovation firmographics

Firmographics
Name
Exactis Innovation
Website
https://exactis.ca
Company type
Private
Founded year
2014
Headcount range
11–50 employees
Short description
Exactis Innovation is a Montreal-based Canadian non-profit clinical trials organization founded in 2014, employing 11–50 staff to support clinical research programs, though its current operating status and specific service scope could not be verified from available sources.
Ownership category
akta.pro rank

Exactis Innovation industry classification

Industry
Product category
Clinical Trials Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAANAI
Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials)

Keywords

  • Clinical trials
  • Cancer research
  • Patient recruitment
  • Biomedical research
  • Clinical research services

Where Exactis Innovation is headquartered

Location

Headquarters

HQ city
Montreal
HQ country
Canada
HQ region
North America

Markets served

Exactis Innovation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Others

Exactis Innovation product offering

Product offering

Core offering

Exactis Innovation is a non-profit clinical trials organization that designs, coordinates, and conducts clinical studies. It operates as a research entity based in Montreal, supporting the development and evaluation of medical therapies through structured trial programs.

Differentiator

Problem solved

Functional benefit

Companies that use Exactis Innovation

Customer profile

Ideal customer profiles1 record

Exactis Innovation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Exactis Innovation competitors and assessment

Company assessment

Others

  • Genome Canada: Canadian non-profit funder of genomics and precision-health research; comparable ecosystem participant whose grants and cohorts can enable precision-trial work similar to what Exactis supports.
  • Canadian Institutes of Health Research (CIHR): Federal funding agency that supports Canadian clinical trial networks; relevant as a comparable non-profit operating environment and likely funder/partner ecosystem for Exactis.

Broad incumbents

  • Veeva Systems: Major life-sciences cloud platform (Vault CDB, Vault CTMS, Vault eTMF); comparable as the dominant commercial infrastructure provider for clinical trials enablement globally.
  • Clario: Global clinical trial endpoint technology and eCOA/ePRO provider; comparable as an enablement partner for decentralized and precision trial designs, though much larger and commercial.
  • Medidata Solutions (Dassault Systèmes): Industry-leading clinical trial technology platform (Rave EDC, Rave RTSM, Medidata AI); the broad incumbent whose software stack is used by most sponsor-led precision trials and which Exactis would partner with or work alongside.

Direct peers

  • Quartesian: Mid-sized clinical data services and biometrics CRO with strong precision-medicine and patient-reported outcomes capabilities; comparable in scale and clinical-trial enablement focus.
  • Ontario Institute for Cancer Research (OICR): Non-profit translational cancer research institute that enables precision-medicine clinical trials in Ontario; directly comparable as a Canadian non-profit in clinical trial enablement for precision oncology.
  • Canadian Cancer Trials Group: Canadian non-profit cooperative oncology trials group based at Queen's University; comparable as a non-profit clinical trials enablement organization operating in Canada with academic and sponsor partnerships.

Emerging players

  • Deep 6 AI: AI-driven patient matching and clinical trial recruitment platform; comparable as a precision-trial enablement player with overlapping patient-matching value proposition.
  • C3 Research Associates: Niche clinical research site network focused on community-based precision trials; comparable as a smaller specialist in trial enablement and site management.

Market position

Strengths3 records

Weaknesses4 records

Key risks4 records

Key highlights3 records

Customer concentration

Exactis Innovation social profiles

Digital presence

Exactis Innovation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Exactis Innovation leadership team

Management profile

Number of profiles

Exactis Innovation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Exactis Innovation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Exactis Innovation

What does Exactis Innovation do?

Exactis Innovation is a non-profit clinical trials organization that designs, coordinates, and conducts clinical studies. It operates as a research entity based in Montreal, supporting the development and evaluation of medical therapies through structured trial programs.

When was Exactis Innovation founded?

Exactis Innovation was founded in 2014. It employs 11 to 50 people.

Where is Exactis Innovation based?

Exactis Innovation is headquartered in Montreal, Canada, in the North America region.

Who are Exactis Innovation's main competitors?

Others on record are Genome Canada and Canadian Institutes of Health Research (CIHR). Broad incumbents are Veeva Systems, Clario and Medidata Solutions (Dassault Systèmes). Direct peers are Quartesian, Ontario Institute for Cancer Research (OICR) and Canadian Cancer Trials Group. Emerging players are Deep 6 AI and C3 Research Associates.

Does Exactis Innovation have an API?

No public API is recorded for Exactis Innovation.

What industry is Exactis Innovation in?

Exactis Innovation's product category is Clinical Trials Services. Its primary akta.pro industry code is HLAAANAI, Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireExactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data AnalyticsExactis Innovation and SOPHiA GENETICS announced a collaboration to use SOPHiA's multimodal real-world data platform for cancer research in Canada. Exactis will join the SOPHiA DDM network, gaining access to global data insights for its 16 Canadian cancer sites and nearly 10,000 patients. The partnership aims to improve cancer survivorship through data-driven decision-making.YahooExactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data AnalyticsExactis Innovation and SOPHiA GENETICS announced a collaboration to use SOPHiA's multimodal data platform for cancer research in Canada. Exactis will access global real-world data insights and implement cancer testing solutions like MSK-ACCESS and MSK-IMPACT. The partnership aims to improve cancer survivorship through data-driven decision-making.GlobeNewswireSermonix Pharmaceuticals Partners With Exactis Innovation for ELAINE 1 Clinical Trial Sites in CanadaSermonix Pharmaceuticals announced a collaboration with Exactis Innovation to add Canadian sites to its ELAINE 1 Phase 2 trial of lasofoxifene. The open-label study, assessing lasofoxifene versus fulvestrant in ESR1-mutated breast cancer, will now include sites in Quebec, Ontario, Nova Scotia, and New Brunswick. Exactis will use its PMT registry to pre-screen patients for ESR1 mutations.PR NewswireExactis Innovation Selects Ion GeneStudio S5 Systems and Oncomine Assays to Drive Canadian Clinical Trial StudiesExactis Innovation, a Canadian non-profit precision cancer research organization, has selected Thermo Fisher Scientific's Ion GeneStudio S5 Series systems and Oncomine assays to support national clinical trial studies across Canada. The program, expected to process up to 2,000 samples annually through 12 academic cancer centers and five regional NGS hubs, aims to molecularly profile cancer patients and expedite enrollment in targeted therapy trials. The collaboration positions Exactis to expand its biopsy-led patient registry and attract pharma partners by offering comprehensive tumor profiling including solid tumor, liquid biopsy, and immune-oncology analyses.